| |
Attend Fusion 2023, a free virtual conference. Whether your involvement is in brand, commercial tech, sales operations, or adjacent roles, these sessions are designed to provide fresh ideas and provoke critical thinking around data, tech, and analytics. Register now! .png)
|
|
| By Annalee Armstrong Eli Lilly’s Alzheimer’s disease candidate has achieved a 35% slowing of cognitive decline and a 39% lower risk of advancing to the next stage of the disease when compared to placebo. |
|
|
|
By Angus Liu A New Jersey appellate court ruled that a group of insurers can’t use war as an argument to deny Merck coverage from the notorious NotPetya cyberattack in 2017. |
By Ben Adams Welcome to the breakdown of the top 10 biggest drug ad spenders in pharma for 2022 as we reveal who funneled the most cash into their campaigns. |
By Max Bayer Pfizer is axing a handful of midstage medicines, most of which stemmed from the company's acquisition of Arena Pharmaceuticals. Company executives also noted on its first-quarter earnings call that it remains on the M&A hunt even after acquiring Seagen for almost $50 billion. |
By Angus Liu Workers at GSK’s Montrose facility in Scotland on Tuesday kicked off a series of strikes that will sequentially affect six of the company’s sites and last throughout May. |
By Angus Liu A panel of external experts for the FDA voted 11 to 1 in support of a narrow approval for AstraZeneca and Merck's Lynparza in metastatic castration-resistant prostate cancer (mCRPC). A comment from FDA's oncology chief Rick Pazdur, M.D., likely played a crucial part in Friday's vote outcome. |
By Conor Hale After collecting a long-awaited FDA clearance for the latest generation of its wearable continuous glucose monitor last December, Dexcom has offered a peek into the momentum behind its G7 diabetes sensor. |
By Helen Floersh The scientists who used CRISPR to eliminate HIV in mice have done it again, this time with a three-pronged approach that nearly doubled their success rate. |
By James Waldron Johnson & Johnson may have gone quiet on getting further CAR-Ts into the clinic beyond the success of its Legend-partnered Carvykti, but that’s about to change. |
By Kevin Dunleavy A labeling problem has forced Teva to recall 13 lots of fentanyl buccal tablets. Safety updates on the product insert were omitted, leaving the possibility of misuse that “could lead to life-threatening adverse events,” the FDA said. |
By Ben Adams Two biotechs are making their old selves walk the plank as they take on new names in the hopes of a bounteous future. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we're continuing our miniseries on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription. |
|
|---|
|
|
Whitepaper Discover the new gold standard for gene therapy protein expression potency measurements. Sponsored by: Bio-Techne |
eBook Discover a game-changing approach to clinical research with Hybrid and Decentralized Clinical Trials (DCTs). Learn about the benefits, challenges, and key elements for success. Sponsored by: EvidentIQ |
Research What role do the Library and Legal teams play in the drug development pipeline at Lilly? An import one – find out how. Sponsored by: CCC |
Whitepaper This paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Research Strategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
Whitepaper How can eConsent provide a more flexible approach to informed consent? Sponsored by: YPrime |
Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
Whitepaper Learn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
Whitepaper Explore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| July 18-19, 2023 | Jersey City, NJ |
|
|
| |
|
.png){kind=logo}
